OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natural products and mitochondrial allies in colorectal cancer therapy
Wei Feng, Qing Nian, Maoyuan Zhao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115473-115473
Open Access | Times Cited: 14

Showing 14 citing articles:

Natural products and derivatives in renal, urothelial and testicular cancers: Targeting signaling pathways and therapeutic potential
Dengxiong Li, Jie Wang, Zhouting Tuo, et al.
Phytomedicine (2024) Vol. 127, pp. 155503-155503
Closed Access | Times Cited: 11

Suppressing the progression of bladder cancer using cyclovirobuxine D based on network pharmacology and bioinformatics approaches
Ke Gao, Hanbing Jiang, Chao Zhang, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access

Endophytic fungi and age-related diseases: Potential for geriatric therapeutics
Rachan Karmakar, Sunil Kumar, Vijay Tripathi, et al.
Elsevier eBooks (2025), pp. 295-313
Closed Access

Mitochondrial Quality Control: A Promising Target of Traditional Chinese Medicine in the Treatment of Cardiovascular Disease
Deng Pan, Pengfei Chen, He Zhang, et al.
Pharmacological Research (2025), pp. 107712-107712
Open Access

Targeting cancer-cell mitochondria using Tigecycline improves radiotherapy response in colorectal cancer cell line
Sepideh Khodaei, Shahnaz Sabetkam, Zeinab Mazloumi, et al.
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis (2025) Vol. 830, pp. 111905-111905
Closed Access

A comprehensive review of phytochemicals targeting macrophages for the regulation of colorectal cancer progression
Yi Yang, Maoyuan Zhao, Qi-Xuan Kuang, et al.
Phytomedicine (2024) Vol. 128, pp. 155451-155451
Closed Access | Times Cited: 3

Therapeutic Potential of Terpenoids in Cancer Treatment: Targeting Mitochondrial Pathways
Jianxin Guo, Ming Huang, Shuang Hou, et al.
Cancer Reports (2024) Vol. 7, Iss. 9
Open Access | Times Cited: 2

Exploring natural resources: Plumbagin as a potent anticancer agent
Iftikhar Ahmad, Shams Tabrez
South African Journal of Botany (2024) Vol. 174, pp. 167-179
Closed Access | Times Cited: 2

Combinational delivery of berbamine and 5-fluorouracil in cerium oxide nanoparticles for colon cancer therapy: Insights from in vitro and in silico studies
Sneha Shriparna Satpathy, Sweta Mishra, Saswati Pattnaik, et al.
European Journal of Medicinal Chemistry Reports (2024) Vol. 12, pp. 100224-100224
Open Access | Times Cited: 1

[Pristimerin enhances cisplatin-induced apoptosis in nasopharyngeal carcinoma cells
Yingying Wang, Tian Chen, Xianling Cong, et al.
PubMed (2024) Vol. 44, Iss. 5, pp. 904-912
Closed Access

Atorvastatin can inhibit ovarian cancer by decreasing VEGF, TGF-β1 and increasing cytochrome-c and caspase-3 expressions
Hongju Chen, H. Shi, X.S. Jiang
Acta Poloniae Pharmaceutica - Drug Research (2024) Vol. 81, Iss. 2, pp. 299-308
Open Access

Page 1

Scroll to top